Zou Tian-Hui, Wang Zhen-Hua, Fang Jing-Yuan
GI Division, Shanghai Jiao-Tong University School of Medicine Renji Hospital, Shanghai Institution of Digestive Disease, Key Laboratory of Gastroenterology and Hepatology, Middle Shandong Road, Shanghai, 200001, China.
Tumour Biol. 2013 Aug;34(4):2441-50. doi: 10.1007/s13277-013-0795-y. Epub 2013 Apr 17.
Several studies have investigated the association between the Toll-like receptor 4 (TLR4) gene +896A/G polymorphism and gastric carcinogenesis, including gastric cancer and precancerous gastric lesions. However, published results are inconsistent. So, we performed a meta-analysis to assess whether the TLR4 +896A/G single-nucleotide polymorphism (SNP) is a risk factor in gastric cancer development. We searched PubMed and Embase databases for studies that reported the odds ratio (OR) and 95 % confidence interval (CI) for the association between the TLR4 +896A/G SNP and the risk of gastric cancer and/or precancerous lesions with the last update of November 2012. Data were analyzed using Review Manager (Version 5.1), and publication bias was estimated. We included 10 study populations, comprising 2,233 cases and 2,849 controls from 8 publications. The pooled OR was 2.00 (95 % CI = 1.59-2.53) for the G allelic model. Analysis stratified by different stages and anatomic sites of neoplasia resulted in a significantly increased risk associated with gastric cancer (OR = 1.87, 95 % CI = 1.44-2.44), especially the non-cardia subtype (OR = 2.03, 95 % CI = 1.51-2.72). Besides, the G allele emerged as a strong risk factor for precancerous gastric lesions (OR = 2.47, 95 % CI = 1.57-3.88). A subsequent subgroup analysis by Helicobacter pylori-positive ratio in cases (>80 %) indicated an enhancement in the association with precancerous lesions (OR = 3.43, 95 % CI = 1.92-6.13). The TLR4 +896A/G SNP is a risk factor in gastric carcinogenesis, especially in H. pylori-infected patients with precancerous lesions.
多项研究探讨了Toll样受体4(TLR4)基因+896A/G多态性与胃癌发生之间的关联,包括胃癌和癌前胃病变。然而,已发表的结果并不一致。因此,我们进行了一项荟萃分析,以评估TLR4 +896A/G单核苷酸多态性(SNP)是否为胃癌发生的危险因素。我们在PubMed和Embase数据库中检索了截至2012年11月最新更新的报告TLR4 +896A/G SNP与胃癌和/或癌前病变风险之间关联的比值比(OR)和95%置信区间(CI)的研究。使用Review Manager(版本5.1)对数据进行分析,并评估发表偏倚。我们纳入了10个研究人群,包括来自8篇出版物的2233例病例和2849例对照。G等位基因模型的合并OR为2.00(95%CI = 1.59 - 2.53)。按肿瘤不同阶段和解剖部位分层分析显示,与胃癌相关的风险显著增加(OR = 1.87,95%CI = 1.44 - 2.44),尤其是非贲门亚型(OR = 2.03,95%CI = 1.51 - 2.72)。此外,G等位基因是癌前胃病变的一个强危险因素(OR = 2.47,95%CI = 1.57 - 3.88)。随后按病例中幽门螺杆菌阳性率(>80%)进行的亚组分析表明,与癌前病变的关联增强(OR = 3.43,95%CI = 1.92 - 6.13)。TLR4 +896A/G SNP是胃癌发生的危险因素,尤其是在幽门螺杆菌感染的癌前病变患者中。